Product
TX200-TR101
Aliases
CAR-Tregs
1 clinical trial
2 indications
Indication
Kidney Transplant RejectionIndication
End-Stage Renal DiseaseClinical trial
Multicentre Open-Label Single Ascending Dose Dose-Ranging Phase I/IIa Study to Evaluate Safety and Tolerability of an Autologous Antigen-Specific Chimeric Antigen Receptor TRegulatory Cell Therapy in Living Donor Renal Transplant RecipientsStatus: Active (not recruiting), Estimated PCD: 2024-11-13